These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11948457)

  • 1. PPARgamma-mediated antineoplastic effect of NSAID sulindac on human oral squamous carcinoma cells.
    Nikitakis NG; Hebert C; Lopes MA; Reynolds MA; Sauk JJ
    Int J Cancer; 2002 Apr; 98(6):817-23. PubMed ID: 11948457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nonsteroidal anti-inflammatory drug sulindac causes down-regulation of signal transducer and activator of transcription 3 in human oral squamous cell carcinoma cells.
    Nikitakis NG; Hamburger AW; Sauk JJ
    Cancer Res; 2002 Feb; 62(4):1004-7. PubMed ID: 11861373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression and NSAID-induced apoptosis in malignant melanomas are independent of cyclooxygenase II.
    Vogt T; McClelland M; Jung B; Popova S; Bogenrieder T; Becker B; Rumpler G; Landthaler M; Stolz W
    Melanoma Res; 2001 Dec; 11(6):587-99. PubMed ID: 11725205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors.
    Richter M; Weiss M; Weinberger I; Fürstenberger G; Marian B
    Carcinogenesis; 2001 Jan; 22(1):17-25. PubMed ID: 11159736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
    He Q; Luo X; Huang Y; Sheikh MS
    Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: possible link to apoptosis.
    Bottone FG; Martinez JM; Collins JB; Afshari CA; Eling TE
    J Biol Chem; 2003 Jul; 278(28):25790-801. PubMed ID: 12734198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.
    Piazza GA; Rahm AK; Finn TS; Fryer BH; Li H; Stoumen AL; Pamukcu R; Ahnen DJ
    Cancer Res; 1997 Jun; 57(12):2452-9. PubMed ID: 9192825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells.
    Nikitakis NG; Siavash H; Hebert C; Reynolds MA; Hamburger AW; Sauk JJ
    Br J Cancer; 2002 Dec; 87(12):1396-403. PubMed ID: 12454768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulindac and exisulind exhibit a significant antiproliferative effect and induce apoptosis in human hepatocellular carcinoma cell lines.
    Rahman MA; Dhar DK; Masunaga R; Yamanoi A; Kohno H; Nagasue N
    Cancer Res; 2000 Apr; 60(8):2085-9. PubMed ID: 10786664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.
    Shureiqi I; Chen D; Lotan R; Yang P; Newman RA; Fischer SM; Lippman SM
    Cancer Res; 2000 Dec; 60(24):6846-50. PubMed ID: 11156377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer.
    Babbar N; Ignatenko NA; Casero RA; Gerner EW
    J Biol Chem; 2003 Nov; 278(48):47762-75. PubMed ID: 14506281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines.
    Lim JT; Piazza GA; Han EK; Delohery TM; Li H; Finn TS; Buttyan R; Yamamoto H; Sperl GJ; Brendel K; Gross PH; Pamukcu R; Weinstein IB
    Biochem Pharmacol; 1999 Oct; 58(7):1097-107. PubMed ID: 10484067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growth.
    Williams CS; Goldman AP; Sheng H; Morrow JD; DuBois RN
    Neoplasia; 1999 Jun; 1(2):170-6. PubMed ID: 10933052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.
    Piazza GA; Rahm AL; Krutzsch M; Sperl G; Paranka NS; Gross PH; Brendel K; Burt RW; Alberts DS; Pamukcu R
    Cancer Res; 1995 Jul; 55(14):3110-6. PubMed ID: 7606732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oncogenic effects of constitutive Stat3 signaling in salivary gland cancer cells are mediated by survivin and modulated by the NSAID sulindac.
    Nikitakis NG; Scheper MA; Papanikolaou VS; Sauk JJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jun; 107(6):826-36. PubMed ID: 19272804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-independent antineoplastic effects of sulindac in oral cancer are mediated by survivin down-regulation.
    Scheper MA; Sauk JJ; Nikitakis NG
    Anticancer Res; 2006; 26(6B):4103-13. PubMed ID: 17201121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal anti-inflammatory drugs inhibit growth of human neuroendocrine tumor cells via G1 cell-cycle arrest.
    Detjen KM; Welzel M; Wiedenmann B; Rosewicz S
    Int J Cancer; 2003 Dec; 107(5):844-53. PubMed ID: 14566837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells.
    Yip-Schneider MT; Sweeney CJ; Jung SH; Crowell PL; Marshall MS
    J Pharmacol Exp Ther; 2001 Sep; 298(3):976-85. PubMed ID: 11504793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth.
    Wick M; Hurteau G; Dessev C; Chan D; Geraci MW; Winn RA; Heasley LE; Nemenoff RA
    Mol Pharmacol; 2002 Nov; 62(5):1207-14. PubMed ID: 12391285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.
    Molina MA; Sitja-Arnau M; Lemoine MG; Frazier ML; Sinicrope FA
    Cancer Res; 1999 Sep; 59(17):4356-62. PubMed ID: 10485483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.